Literature DB >> 380856

Specificity of the macrophage spreading test with reference to Leishmania antigens and correlation with delayed hypersensitivity.

A Matossian-Rogers.   

Abstract

The inhibition of the macrophage spreading test, claimed to be an in vitro correlate of delayed hypersensitivity, was examined in guinea-pigs immunized with L. enriettii and L. tropica soluble antigens. Cells from peritoneal washings of the guinea-pigs were tested in presence of the homologous and heterologous antigens and also without antigen. Inhibition of macrophage spreading compared to control preparations was noted only in the presence of the homologous antigen when the skin test response of the donor animal was relatively small. The degree of inhibition decreased as the skin test volume increased and when skin test volumes were large there was actual stimulation of macrophage spreading, rather than inhibition. The addition of heterologous antigen to the peritoneal cell preparation always resulted in the augmentation of macrophage spreading above control levels. The possible mechanisms of this in vitro technique and its use as a taxonomic or diagnostic tool are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 380856      PMCID: PMC1537692     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  DELAYED HYPERSENSITIVITY IN VITRO. I. THE SPECIFICITY OF INHIBITION OF CELL MIGRATION BY ANTIGENS.

Authors:  J R DAVID; S AL-ASKARI; H S LAWRENCE; L THOMAS
Journal:  J Immunol       Date:  1964-08       Impact factor: 5.422

2.  In vitro cell migration as a model for delayed hypersensitivity.

Authors:  M GEORGE; J H VAUGHAN
Journal:  Proc Soc Exp Biol Med       Date:  1962-11

Review 3.  Cell migration inhibition: an appraisal.

Authors:  J Morley
Journal:  Acta Allergol       Date:  1974-06

4.  Immunity in cutaneous leishmaniasis of the guinea-pig.

Authors:  A D Bryceson; R S Bray; R A Wolstencroft; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1970-09       Impact factor: 4.330

5.  Implantation of a foetal thymus, restoring immunological competence in a patient with thymic aplasia (Digeorge's syndrome).

Authors:  C S August; F S Rosen; R M Filler; C A Janeway; B Markowski; H E Kay
Journal:  Lancet       Date:  1968-12-07       Impact factor: 79.321

6.  Congenital aplasia of the thymus gland (DiGeorge's syndrome).

Authors:  R Kretschmer; B Say; D Brown; F S Rosen
Journal:  N Engl J Med       Date:  1968-12-12       Impact factor: 91.245

7.  Inhibition of monocyte spreading. A direct in vitro test for assessing delayed-type hypersensitivity in man.

Authors:  D Dekaris; V Silobrcić; R Mazuran; M Kadrnka-Lovrencić
Journal:  Clin Exp Immunol       Date:  1974-02       Impact factor: 4.330

8.  Production by stimulated macrophages of factors depressing lymphocyte transformation.

Authors:  D S Nelson
Journal:  Nature       Date:  1973-11-30       Impact factor: 49.962

9.  Macrophage spreading: inhibition in delayed hypersensitivity.

Authors:  R M Fauve; D Dekaris
Journal:  Science       Date:  1968-05-17       Impact factor: 47.728

10.  Macrophage receptors for migration inhibitory factor (MIF), migration stimulatory factor (MSF), and agglutinating factor.

Authors:  R A Fox; D S Gregory; J D Feldman
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

View more
  3 in total

1.  Hepatic cells' mitotic and peritoneal macrophage phagocytic activities during Trypanosoma musculi infection in zinc-deficient mice.

Authors:  P A Humphrey; M Ashraf; C M Lee
Journal:  J Natl Med Assoc       Date:  1997-04       Impact factor: 1.798

2.  Interaction of nutrition and infection: macrophage activity in vitamin B12-deficient rats infected with Trypanosoma lewisi.

Authors:  K G Thomaskutty; C M Lee
Journal:  J Natl Med Assoc       Date:  1987-04       Impact factor: 1.798

3.  Trichinella spiralis: changes in leucocytes during infection.

Authors:  C M Lee; Y Best
Journal:  J Natl Med Assoc       Date:  1983-12       Impact factor: 1.798

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.